Search

Biopatch war on infection webinar – Free Registration

“Andrew Jackson IV Nurse Consultant (Rotherham General) will chair some questions to our faculty on best practice and how the lead consultants and vascular access leads have prepared and dealt with COVID 19 and the learnings moving forward”

Noninvasive biofilm biomarker in dialysis vascular access

PICC

“The purpose of this pilot study was to characterize LTA concentrations in hemodialysis (HD) patients with TCVCs compared to other access types and to evaluate biofilm morphology and microbiology in TCVCs removed by clinical decision” Pai et al (2020).

Prolonged versus intermittent infusion of β-Lactam antibiotics

intravenous

“The aim of this study was to describe the pharmacokinetic/pharmacodynamic (PK/PD) indices and targets reported in preclinical models and to compare the bactericidal efficacy of intermittent and prolonged infusions of β-lactam antibiotics” Dhaese et al (2020).

Management of suspected central line-associated bloodstream infections

crbsi

“To assess whether a 24-hour length of hospitalization and empiric antibiotic therapy to exclude central line-associated bloodstream infection (CLABSI) in children with intestinal failure is potentially as safe as 48 hours, which is the duration most commonly used but not evidence based” Fell et al (2020).

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey